Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Phase Genomics revenue
Phase Genomics's revenue is $1.6 million.
What is Phase Genomics's revenue?
- Phase Genomics has 30 employees, and the revenue per employee ratio is $53,333.
- Phase Genomics peak revenue was $1.6M in 2024.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Phase Genomics financing
Phase Genomics received early financing of $1.0M on 2017-12-03.
| Series | Round size | Date |
|---|---|---|
| Seed | $1M | 12/2017 |
| Grant | $1.5M | 06/2018 |
| Grant | $200K | 02/2019 |
| Grant | $1.5M | 01/2020 |
| Grant | $3.9M | 09/2020 |
| Grant | $1.7M | 02/2021 |
Phase Genomics investors
| Investors | Security type |
|---|---|
| Washington Research Foundation | Seed |
| Congruent Ventures | Seed |
| National Institutes of Health (NIH) | Grant |
| Bill & Melinda Gates Foundation | Grant |
| National Institute of Allergy and Infectious Diseases (NIAID) | Grant |
| National Institutes of Health (NIH) | Grant |
| National Institute of Allergy and Infectious Diseases (NIAID) | Grant |
Search for jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Phase Genomics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Phase Genomics. The employee data is based on information from people who have self-reported their past or current employments at Phase Genomics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Phase Genomics. The data presented on this page does not represent the view of Phase Genomics and its employees or that of Zippia.
Phase Genomics may also be known as or be related to Phase Genomics and Phase Genomics, Inc.